Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
California Doles Out Millions to Insurers for Hepatitis C Drugs

In an unusual funding arrangement, California is paying private health plans hundreds of millions of dollars in supplemental payments to cover the high price of hepatitis C drugs for patients in Medi-Cal managed care plans.

Published
29 January 2016
From
KQED News
Kansas Legislators Walk Back On Lifetime Ban For Hepatitis C Drugs

A panel of legislators Friday reversed their recommendation of a lifetime ban on hepatitis C drugs for Medicaid patients who don’t comply with their treatment regimen.

Published
24 January 2016
From
KCUR
Building patient groups for viral hepatitis – a new online resource for healthcare professionals

In this guest blog, Jeffrey Lazarus talks about the importance of patient groups for viral hepatitis and introduces a new tool launched by the World Hepatitis Alliance.

Published
22 January 2016
From
BMC Blogs Network (blog)
Cardiovascular disease risk is higher for people with hepatitis C

People with hepatitis C are at higher risk of dying from cardiovascular disease suffering a stroke or developing cardiovascular problems than people with similar risk

Published
22 January 2016
By
Keith Alcorn
D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

Long-term therapy with the antiretroviral drug tenofovir increases the risk of end-stage liver disease and liver cancer, according to data from the D:A:D study published

Published
21 January 2016
By
Michael Carter
Hepatitis Testing Contest

Our team in collaboration with the WHO Global Hepatitis Program is organizing an innovation contest on hepatitis B and C testing. The purpose of this contest is to identify innovative examples of delivering hepatitis B and C testing that will be highlighted within the 2016 WHO Hepatitis Testing Guidelines.

Published
19 January 2016
From
Social Entrepreneurship for Sexual Health
The 2016 Hepatitis C Drug Approval Outlook

Here’s what’s in store this year for new hepatitis C therapies, as well as approvals for new uses of existing treatments.

Published
18 January 2016
From
Poz
European Union Joint Action on HIV and Co - infection Prevention and Harm Reduction launched

On 14-15 January 2016 in Vilnius, Lithuania, the European Union Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) held its first Partnership Forum to kick off activities. HA-REACT addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID).

Published
18 January 2016
From
Manual Items
High rates of modifiable cancer risk factors present in Western HIV-positive patients

The prevalence of potentially modifiable risk factors for some cancers is “extraordinarily high” among people with HIV, according to results of a meta-analysis published in

Published
18 January 2016
By
Michael Carter
Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Long-term use of Viread (tenofovir disoproxil fumarate, or TDF) is associated with an increased risk of end-stage liver disease (ESLD) as well as hepatocellular carcinoma (HCC, the most common form of liver cancer) among people with HIV.

Published
14 January 2016
From
Poz

Filter by country